PMV Pharmaceuticals, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
PMV Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • PMV Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $371K, a 3.63% increase year-over-year.
  • PMV Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.46M, a 50.5% increase year-over-year.
  • PMV Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.26M, a 299% increase from 2022.
  • PMV Pharmaceuticals, Inc. annual Depreciation for 2022 was $315K, a 2.61% increase from 2021.
  • PMV Pharmaceuticals, Inc. annual Depreciation for 2021 was $307K, a 3.46% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.26M +$942K +299% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $315K +$8K +2.61% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $307K -$11K -3.46% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $318K -$70K -18% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $388K +$50K +14.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $338K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.